Literature DB >> 27034076

[Caspase-1 regulates autoinflammation in rheumatic diseases].

S Winkler1, C M Hedrich2, A Rösen-Wolff2.   

Abstract

Caspase-1 is an integral regulator of the innate immune system. Its core functions are the processing and secretion of the proinflammatory cytokines interleukin 1β (IL-1 beta) and IL-18 and the initiation of proinflammatory cell death, which is referred to as pyroptosis. Activation of caspase-1 plays a pivotal role during immune defense mechanisms against infections by the innate immune system. Dysregulated activation of caspase-1 has been recognized to be involved in the pathophysiology of a constantly increasing number of inflammatory diseases. This article gives an overview of the regulation and function of caspase-1 and its involvement in monogenic, polygenic and/or polyetiological rheumatic diseases.

Entities:  

Keywords:  Cytokines; Immune system; Inflammasomes; Pyroptosis; Targeted therapy

Mesh:

Substances:

Year:  2016        PMID: 27034076     DOI: 10.1007/s00393-016-0077-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  126 in total

Review 1.  Current understanding of the pathophysiology of systemic juvenile idiopathic arthritis (sJIA) and target-directed therapeutic approaches.

Authors:  Normi Bruck; Anja Schnabel; Christian M Hedrich
Journal:  Clin Immunol       Date:  2015-05-06       Impact factor: 3.969

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

3.  IL10 promoter polymorphisms are associated with systemic onset juvenile idiopathic arthritis (SoJIA).

Authors:  J C Möller; D Paul; G Ganser; U Range; M Gahr; R Kelsch; A Rösen-Wolff; C M Hedrich
Journal:  Clin Exp Rheumatol       Date:  2011-01-04       Impact factor: 4.473

Review 4.  Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes.

Authors:  Ellen K Grishman; Perrin C White; Rashmin C Savani
Journal:  Pediatr Res       Date:  2012-02-15       Impact factor: 3.756

Review 5.  Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies.

Authors:  Giulio Cavalli; Charles A Dinarello
Journal:  Rheumatology (Oxford)       Date:  2015-07-23       Impact factor: 7.580

6.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.

Authors:  Edward A Miao; Dat P Mao; Natalya Yudkovsky; Richard Bonneau; Cynthia G Lorang; Sarah E Warren; Irina A Leaf; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

7.  Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.

Authors:  C M Hedrich; B Fiebig; S Sallmann; N Bruck; G Hahn; J Roesler; A Roesen-Wolff; G Heubner; M Gahr
Journal:  Scand J Rheumatol       Date:  2008 Sep-Oct       Impact factor: 3.641

8.  Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis.

Authors:  Timothy Beukelman; James P Guevara; Daniel A Albert
Journal:  Arthritis Rheum       Date:  2008-11-15

9.  Novel IL10 gene family associations with systemic juvenile idiopathic arthritis.

Authors:  Mark S Fife; Ana Gutierrez; Emma M Ogilvie; Carmel J W Stock; Jane M Samuel; Wendy Thomson; Lisa F Mack; Cathryn M Lewis; Patricia Woo
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.

Authors:  Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more
  3 in total

1.  Serum Interleukin-6 and CCL11/Eotaxin May Be Suitable Biomarkers for the Diagnosis of Chronic Nonbacterial Osteomyelitis.

Authors:  Sigrun Ruth Hofmann; Fanny Böttger; Ursula Range; Christian Lück; Henner Morbach; Hermann Joseph Girschick; Meinolf Suttorp; Christian Michael Hedrich
Journal:  Front Pediatr       Date:  2017-12-01       Impact factor: 3.418

Review 2.  Vasculitis in Cystic Fibrosis.

Authors:  Francesca Sposito; Paul S McNamara; Christian M Hedrich
Journal:  Front Pediatr       Date:  2020-11-12       Impact factor: 3.418

3.  Expression of Caspase-1 in breast cancer tissues and its effects on cell proliferation, apoptosis and invasion.

Authors:  Yanxia Sun; Yingzhen Guo
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.